Visirna Therapeutics Hk Limited
Clinical trials sponsored by Visirna Therapeutics Hk Limited, explained in plain language.
-
New injection aims to tame dangerous fat levels in rare disorder
Disease control CompletedThis study tested an experimental injection called Plozasiran in Chinese adults with familial chylomicronemia syndrome (FCS), a rare genetic disorder that causes extremely high levels of fat in the blood. The main goal was to see if the injection could safely and effectively lowe…
Phase: PHASE3 • Sponsor: Visirna Therapeutics HK Limited • Aim: Disease control
Last updated Mar 02, 2026 15:21 UTC
-
First human test for new cholesterol drug completed
Knowledge-focused CompletedThis was a first-in-human study to check the safety and basic effects of a single dose of an experimental drug called VSA003. It involved 36 healthy Chinese adult volunteers. The main goal was to see how the body processes the drug and to monitor for any side effects.
Phase: PHASE1 • Sponsor: Visirna Therapeutics HK Limited • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC